Literature DB >> 8174437

Attenuation of acetaminophen hepatitis by prostaglandin E2. A histopathological study.

G L Monto1, P J Scheuer, R L Hansing, A K Burroughs.   

Abstract

Acute acetaminophen hepatitis was produced in three groups of five rats given 1600 mg/kg by gavage. The protective effect of 16,16-dimethyl prostaglandin E2, 200 micrograms/kg administered subcutaneously 30 min later, was compared to the protective effect of N-acetylcysteine 1 g/kg similarly administered. All animals were killed at 24 hr, and liver tissues were compared histologically to the damage found in acetaminophen-treated controls and untreated anatomic controls. Serum transaminase values at 24 hr exceeded 1000 units in the acetaminophen control group, averaged 658 units in the acetylcysteine treated group, and were near normal (75 units) in the prostaglandin treated group (P < 0.02). Liver samples (1 cm3) were removed terminally at 24 hr. Liver damage was assessed without reference to precedent history. Histopathologically, damage was most severe in the acetaminophen control group, mainly in pericentral lobular zones. The prostaglandin-treated group showed considerably less damage, which was confined to the hepatic vein area. The acetylcysteine-treated group showed an intermediate degree of damage. We conclude that dmPGE2, given 30 min after ingestion of acetaminophen was found to be more effective in limiting liver damage than NAC in this rat model.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174437     DOI: 10.1007/bf02087543

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Serum glutamic pyruvic transaminase in cardiac with hepatic disease.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1956-04

2.  Liver parenchymal cell injury. V. Relationships between patterns of chloromethane-C 14 incorporation into constituents of liver in vivo and cellular injury.

Authors:  E S Reynolds; A G Yee
Journal:  Lab Invest       Date:  1967-04       Impact factor: 5.662

3.  Hepatocytoprotective substances.

Authors:  R F Burk
Journal:  Gastroenterology       Date:  1981-08       Impact factor: 22.682

4.  Lipoperoxidation as a vector in carbon tetrachloride hepatotoxicity.

Authors:  R O Recknagel; A K Ghoshal
Journal:  Lab Invest       Date:  1966-01       Impact factor: 5.662

5.  Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice.

Authors:  G B Corcoran; W J Racz; C V Smith; J R Mitchell
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

6.  Early indicators of prognosis in fulminant hepatic failure.

Authors:  J G O'Grady; G J Alexander; K M Hayllar; R Williams
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

7.  Protection by propylthiouracil against carbon tetrachloride-induced liver damage.

Authors:  H Orrego; F J Carmichael; M J Phillips; H Kalant; J Khanna; Y Israel
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

8.  Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury.

Authors:  N Masaki; Y Ohta; H Shirataki; I Ogata; S Hayashi; S Yamada; K Hirata; S Nagoshi; S Mochida; T Tomiya
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

9.  Protective effects of 16,16-dimethyl PGE2 on the liver and kidney.

Authors:  M J Ruwart; B D Rush; N M Friedle; R C Piper; G J Kolaja
Journal:  Prostaglandins       Date:  1981

10.  Cytoprotective effect of 16, 16' dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat.

Authors:  J Stachura; A Tarnawski; J Szczudrawa; J Bogdał; T Mach; B Klimczyk; S Kirchmayer
Journal:  Folia Histochem Cytochem (Krakow)       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.